Scinai Immunotherapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-DANIEL E. STONE(7.4%)
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data
No Data